|
|
|
Insider
Information: |
Martin John C |
Relationship: |
Director |
City: |
Foster City |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
2,895,138 |
|
Indirect Shares
|
2,684,281 |
|
|
Direct
Value |
$186,589,533 |
|
|
Indirect Value
|
$47,040,306 |
|
|
Total
Shares |
5,579,419 |
|
|
Total
Value |
$233,629,839 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Gilead Sciences Inc |
GILD |
Director |
2019-02-06 |
2,887,225 |
2016-08-05 |
731,917 |
Premium* |
|
Sarepta Therapeutics Inc |
SRPT |
Director |
2021-03-03 |
7,913 |
2020-02-28 |
0 |
Premium* |
|
Kronos Bio, Inc. |
KRON |
Director |
2020-10-14 |
0 |
2020-10-14 |
1,952,364 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
367 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 6 of 15
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2013-07-01 |
4 |
OE |
$7.63 |
$2,154,212 |
D/D |
282,242 |
4,339,363 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2013-08-01 |
4 |
AS |
$61.55 |
$17,389,740 |
D/D |
(282,242) |
4,057,121 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2013-08-01 |
4 |
OE |
$7.63 |
$2,154,212 |
D/D |
282,242 |
4,339,363 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2013-09-03 |
4 |
OE |
$7.63 |
$2,154,212 |
D/D |
282,242 |
4,339,363 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2013-09-03 |
4 |
AS |
$60.95 |
$17,209,490 |
D/D |
(282,242) |
4,057,121 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2013-10-01 |
4 |
AS |
$62.70 |
$17,696,545 |
D/D |
(282,242) |
4,057,121 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2013-10-01 |
4 |
OE |
$7.63 |
$2,154,212 |
D/D |
282,242 |
4,339,363 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2013-11-01 |
4 |
AS |
$70.83 |
$19,990,213 |
D/D |
(282,242) |
4,057,121 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2013-11-01 |
4 |
OE |
$7.63 |
$2,154,212 |
D/D |
282,242 |
4,339,363 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2013-12-02 |
4 |
OE |
$7.63 |
$2,154,212 |
D/D |
282,242 |
4,339,363 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2013-12-02 |
4 |
AS |
$74.23 |
$20,960,697 |
D/D |
(282,242) |
4,057,121 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2014-01-02 |
4 |
OE |
$8.01 |
$1,125,703 |
D/D |
140,625 |
4,197,746 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2014-01-02 |
4 |
AS |
$75.02 |
$10,550,180 |
D/D |
(140,625) |
4,057,121 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2014-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
121,146 |
4,256,267 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2014-02-03 |
4 |
AS |
$79.05 |
$11,244,089 |
D/D |
(140,625) |
4,256,267 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2014-02-03 |
4 |
OE |
$8.01 |
$1,125,703 |
D/D |
140,625 |
4,396,892 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2014-02-14 |
4 |
A |
$21.94 |
$21,243 |
D/D |
968 |
4,257,235 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2014-03-03 |
4 |
OE |
$8.01 |
$1,125,703 |
D/D |
140,625 |
4,397,860 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2014-03-03 |
4 |
AS |
$81.49 |
$11,495,326 |
D/D |
(140,625) |
4,257,235 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2014-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
360,000 |
4,617,235 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2014-03-06 |
4 |
D |
$79.92 |
$15,012,812 |
D/D |
(187,848) |
4,429,387 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2014-04-01 |
4 |
AS |
$73.06 |
$10,302,028 |
D/D |
(140,625) |
4,429,387 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2014-04-01 |
4 |
OE |
$8.01 |
$1,125,703 |
D/D |
140,625 |
4,570,012 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2014-05-01 |
4 |
OE |
$8.01 |
$1,125,703 |
D/D |
140,625 |
4,570,012 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2014-05-01 |
4 |
AS |
$78.64 |
$11,112,034 |
D/D |
(140,625) |
4,429,387 |
0 |
- |
|
367 Records found
|
|
Page 6 of 15 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|